On June 23, 2025, TuHURA Biosciences, Inc. held a special meeting where stockholders approved several proposals, including increasing authorized shares from 75 million to 200 million and merging with Kineta, Inc. Voting results showed significant support for these proposals, indicating shareholder confidence in upcoming transitions.